Article Text

Download PDFPDF
Assessing quality of life in clinical trials, 2nd ed
  1. Jacqueline Müller-Nordhorn

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    P Fayers, R Hays. Oxford University Press, 2005.

    Health related quality of life is increasingly used as an end point in clinical trials. Particularly, in diseases with a poor prognosis such as metastatic cancer, quality of life may be of major concern. However, clinicians are still reluctant to accept quality of life as an end point equivalent to more “objective” end points such as size of the tumour as assessed by imaging or disease free survival in patients with cancer. Having to deal with practical and time consuming issues such as randomisation, informed consent, and the organisation of study medication when enrolling …

    View Full Text